Key details
Sponsor
Mohamed Maher Ismail Ahmed Elashmawy
Enrollment target
~46 participants
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated January 2025